Drug Type Therapeutic vaccine |
Synonyms TNF-K, TNFα-kinoid, TNF-K005 |
Target |
Mechanism TNF-α inhibitors(Tumor necrosis factor α inhibitors) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rheumatoid Arthritis | Phase 2 | BE | 01 Sep 2013 | |
Rheumatoid Arthritis | Phase 2 | GE | 01 Sep 2013 | |
Rheumatoid Arthritis | Phase 2 | HU | 01 Sep 2013 | |
Rheumatoid Arthritis | Phase 2 | LB | 01 Sep 2013 | |
Rheumatoid Arthritis | Phase 2 | MD | 01 Sep 2013 | |
Rheumatoid Arthritis | Phase 2 | MK | 01 Sep 2013 | |
Rheumatoid Arthritis | Phase 2 | PL | 01 Sep 2013 | |
Rheumatoid Arthritis | Phase 2 | RU | 01 Sep 2013 | |
Rheumatoid Arthritis | Phase 2 | RS | 01 Sep 2013 | |
Rheumatoid Arthritis | Phase 2 | UA | 01 Sep 2013 |
Phase 2 | TNF alpha | 40 | TNF-Kinoid 90 mcg | blfrtzxkqz(nrunloosml) = iagnitcdie pvskuiecan (kkiusaxpah ) View more | - | 06 Jun 2012 | |
Placebo | blfrtzxkqz(nrunloosml) = frmhoaepja pvskuiecan (kkiusaxpah ) View more |